HomeOXB • LON
add
Oxford BioMedica plc
Nakaraang pagsara
GBX 644.00
Sakop ng araw
GBX 630.00 - GBX 668.00
Sakop ng taon
GBX 270.00 - GBX 962.00
Market cap
762.88M GBP
Average na Volume
263.91K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (GBP) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 47.76M | 22.47% |
Gastos sa pagpapatakbo | 20.93M | -0.25% |
Net na kita | -1.88M | 64.80% |
Net profit margin | -3.94 | 71.30% |
Kita sa bawat share | — | — |
EBITDA | -2.06M | -184.23% |
Aktuwal na % ng binabayarang buwis | 36.20% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (GBP) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 96.90M | 59.77% |
Kabuuang asset | 325.72M | 40.61% |
Kabuuang sagutin | 234.37M | 36.94% |
Kabuuang equity | 91.35M | — |
Natitirang share | 120.75M | — |
Presyo para makapag-book | 8.47 | — |
Return on assets | -2.89% | — |
Return on capital | -3.93% | — |
Cash Flow
Net change in cash
| (GBP) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.88M | 64.80% |
Cash mula sa mga operasyon | -1.56M | 72.77% |
Cash mula sa pag-invest | -2.74M | -231.56% |
Cash mula sa financing | 26.21M | 862.37% |
Net change in cash | 21.50M | 307.17% |
Malayang cash flow | -1.40M | -220.21% |
Tungkol
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Wikipedia
Itinatag
1995
Website
Mga Empleyado
977
